These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1414543)

  • 1. Brain oedema and intracranial hypertension treatment by GLIAS.
    Oppido PA; Delfini R; Innocenzi G; Di Giugno G; Pecori-Giraldi J; Santoro A; Virno M; Cantore GP
    Acta Neurochir Suppl (Wien); 1992; 55():40-2. PubMed ID: 1414543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Intravenous treatment of intracranial hypertension and cerebral edema with stabilized solutions of glycerol-sodium ascorbate].
    Cantore GP; Battistini N; Neri L; Delfini R
    Boll Chim Farm; 1981 Jan; 120(1):32-42. PubMed ID: 7236370
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical study of mannitol and glycerol on raised intracranial pressure and on their rebound phenomenon.
    Node Y; Nakazawa S
    Adv Neurol; 1990; 52():359-63. PubMed ID: 2118716
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Long-term behavior of ventricular fluid pressure in automatically controlled infusion therapy with sorbitol and relation to clinical and paraclinical parameters].
    Brachmann J; Goldhahn WE; Dietrich J; Geikler M
    Zentralbl Neurochir; 1987; 48(1):9-17. PubMed ID: 3618008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of glycerol per os in the fundamental treatment of intracranial hypertension].
    Thierry A; Dechaume JP; Friedel M; Plasse JC; Martinet R; Mansuy L
    J Med Lyon; 1966 Oct; 47(106):1355-60. PubMed ID: 5928218
    [No Abstract]   [Full Text] [Related]  

  • 6. Use of hypertonic (3%) saline/acetate infusion in the treatment of cerebral edema: Effect on intracranial pressure and lateral displacement of the brain.
    Qureshi AI; Suarez JI; Bhardwaj A; Mirski M; Schnitzer MS; Hanley DF; Ulatowski JA
    Crit Care Med; 1998 Mar; 26(3):440-6. PubMed ID: 9504569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful treatment of increased intracranial pressure by barbiturate therapy in a patient with severe sinus thrombosis after failure of osmotic therapy. A case report.
    Maruishi M; Kato H; Nawashiro H; Takiguchi H; Shima K; Chigasaki H
    Acta Neurochir (Wien); 1993; 120(1-2):88-91. PubMed ID: 8434523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics and pharmacodynamics of serum glycerol in patients with brain edema: comparison of oral and intravenous administration.
    Tsuyusaki H; Kondo R; Murase S; Yoshiyama Y; Kobayashi T; Takagi H; Kitahara Y; Morii S; Tomonaga F; Ohwada T
    Acta Neurochir Suppl (Wien); 1994; 60():550-1. PubMed ID: 7976647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The University of Toronto head injury treatment study: a prospective, randomized comparison of pentobarbital and mannitol.
    Schwartz ML; Tator CH; Rowed DW; Reid SR; Meguro K; Andrews DF
    Can J Neurol Sci; 1984 Nov; 11(4):434-40. PubMed ID: 6440704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Epidural cerebrospinal fluid pressure measurement and therapy of intracranial hypertension in "malignant" middle cerebral artery infarct].
    Schwab S; Schellinger P; Aschoff A; Albert F; Spranger M; Hacke W
    Nervenarzt; 1996 Aug; 67(8):659-66. PubMed ID: 8805111
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of post-traumatic intracranial hypertension by hypertonic/hyperoncotic saline/dextran and hypertonic mannitol.
    Berger S; Schürer L; Härtl R; Messmer K; Baethmann A
    Neurosurgery; 1995 Jul; 37(1):98-107; discussion 107-8. PubMed ID: 8587698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oral glycerol for the treatment of traumatic intracranial hypertension.
    Wald SL; McLaurin RL
    J Neurosurg; 1982 Mar; 56(3):323-31. PubMed ID: 7057229
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Barbiturate therapy in 16 cases with intracranial lesion with special reference to the indication and limitation].
    Hashimoto M; Kajiwara H; Kadoya C
    J UOEH; 1987 Jun; 9(2):149-56. PubMed ID: 3616259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationships between dopamine infusions and intracranial hemodynamics in patients with raised intracranial pressure.
    Nau R; Sander D; Klingelhöfer J
    Clin Neurol Neurosurg; 1992; 94(2):143-8. PubMed ID: 1324812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of indomethacin on intracranial pressure, cerebral blood flow and cerebral metabolism in patients with severe head injury and intracranial hypertension.
    Jensen K; Ohrström J; Cold GE; Astrup J
    Acta Neurochir (Wien); 1991; 108(3-4):116-21. PubMed ID: 2031471
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertonic saline solution for control of elevated intracranial pressure in patients with exhausted response to mannitol and barbiturates.
    Horn P; Münch E; Vajkoczy P; Herrmann P; Quintel M; Schilling L; Schmiedek P; Schürer L
    Neurol Res; 1999 Dec; 21(8):758-64. PubMed ID: 10596385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dimethyl sulfoxide in the management of patient with brain swelling and increased intracranial pressure after severe closed head injury.
    Kulah A; Akar M; Baykut L
    Neurochirurgia (Stuttg); 1990 Nov; 33(6):177-80. PubMed ID: 2290457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of glymarite on intracranial pressure in the postoperative period of severe craniocerebral injuries and hemorrhagic strokes].
    Saribekian AS; Bebutova LIu
    Zh Vopr Neirokhir Im N N Burdenko; 1984; (2):32-5. PubMed ID: 6429987
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of resistant intracranial hypertension with hypertonic saline. Report of two cases.
    Worthley LI; Cooper DJ; Jones N
    J Neurosurg; 1988 Mar; 68(3):478-81. PubMed ID: 3343621
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical study on reductions of intracranial pressure by therapeutic agents. 2. Effects of glycerol through various administration methods and the rebound phenomenon caused by the agent].
    Node Y
    Nihon Ika Daigaku Zasshi; 1982; 49(6):752-8. PubMed ID: 7166584
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.